The standards are a critical component of the Australian Health Services Safety and Quality Accreditation Scheme. The standards provide a nationally consistent and uniform set of measures of safety and quality for application across a wide variety of health care services. They include evidence-based improvement strategies to deal with gaps between current and best-practice outcomes that affect a large number of patients.
Standard 7 Blood and Blood Products covers elements in the clinical transfusion process, including local governance, clinical practice, documentation, haemovigilance, and wastage. The Standard 7 Blood and Blood Products Safety and Quality Improvement Guide provides guidance for facilities to align transfusion medicine activities with a quality improvement framework.
Since 2007, linked red cell utilisation data from NSW Health's Health Information Exchange (HIE) and local pathology and transfusion laboratory databases has been provided to facilities. This has allowed comparison of red cell usage, including dosage, both between NSW public hospitals and against the State average. Breakdown of usage by diagnosis-related group has also enabled the identification of specific areas of practice variation that may need to be addressed.
NSW Health data is available through the CEC eChartbook portal.
For information on how to access local facility or LHD data, please contact Blood Watch.
Audit is an important part of quality improvement. Audits can be used to review current practice, assess risks, identify improvement opportunities and measure the results of practice improvement activities.
Blood Watch is committed to assisting health facilities to use auditing effectively within a quality improvement framework. This also supports facilities in meet the requirements of Standard 7.
Sample audit tools have been developed to monitor compliance to policies, procedures and/or protocols, and for assessment of practice against national evidence-based guidelines.